ERα was found to increase the expression of miR-218 that was followed by diminished protein expression of tyrosine phosphatase alpha (PTPα), as well as by activation of GSK-3β and inactivation of protein phosphatase 2A, the major tau enzymes involved in AD pathology. Here, MAPT is linked to Alzheimer disease.